345 related articles for article (PubMed ID: 22539346)
1. Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis.
Xiao Q; Gil SC; Yan P; Wang Y; Han S; Gonzales E; Perez R; Cirrito JR; Lee JM
J Biol Chem; 2012 Jun; 287(25):21279-89. PubMed ID: 22539346
[TBL] [Abstract][Full Text] [Related]
2. The role of PTB domain containing adaptor proteins on PICALM-mediated APP endocytosis and localization.
Merthan L; Haller A; Thal DR; von Einem B; von Arnim CAF
Biochem J; 2019 Jul; 476(14):2093-2109. PubMed ID: 31300465
[TBL] [Abstract][Full Text] [Related]
3. Decreasing the expression of PICALM reduces endocytosis and the activity of β-secretase: implications for Alzheimer's disease.
Thomas RS; Henson A; Gerrish A; Jones L; Williams J; Kidd EJ
BMC Neurosci; 2016 Jul; 17(1):50. PubMed ID: 27430330
[TBL] [Abstract][Full Text] [Related]
4. Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy.
Tian Y; Chang JC; Fan EY; Flajolet M; Greengard P
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17071-6. PubMed ID: 24067654
[TBL] [Abstract][Full Text] [Related]
5. Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque Pathogenesis.
Xiao Q; Yan P; Ma X; Liu H; Perez R; Zhu A; Gonzales E; Tripoli DL; Czerniewski L; Ballabio A; Cirrito JR; Diwan A; Lee JM
J Neurosci; 2015 Sep; 35(35):12137-51. PubMed ID: 26338325
[TBL] [Abstract][Full Text] [Related]
6. PICALM and Alzheimer's Disease: An Update and Perspectives.
Ando K; Nagaraj S; Küçükali F; de Fisenne MA; Kosa AC; Doeraene E; Lopez Gutierrez L; Brion JP; Leroy K
Cells; 2022 Dec; 11(24):. PubMed ID: 36552756
[TBL] [Abstract][Full Text] [Related]
7. High glucose-mediated PICALM and mTORC1 modulate processing of amyloid precursor protein via endosomal abnormalities.
Chae CW; Lee HJ; Choi GE; Jung YH; Kim JS; Lim JR; Kim SY; Hwang IK; Seong JK; Han HJ
Br J Pharmacol; 2020 Aug; 177(16):3828-3847. PubMed ID: 32436237
[TBL] [Abstract][Full Text] [Related]
8. Distribution and expression of picalm in Alzheimer disease.
Baig S; Joseph SA; Tayler H; Abraham R; Owen MJ; Williams J; Kehoe PG; Love S
J Neuropathol Exp Neurol; 2010 Oct; 69(10):1071-7. PubMed ID: 20838239
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic processing of Alzheimer's β-amyloid precursor protein.
Zhang H; Ma Q; Zhang YW; Xu H
J Neurochem; 2012 Jan; 120 Suppl 1(Suppl 1):9-21. PubMed ID: 22122372
[TBL] [Abstract][Full Text] [Related]
10. 27-hydroxycholesterol promotes Aβ accumulation via altering Aβ metabolism in mild cognitive impairment patients and APP/PS1 mice.
Zhang X; Xi Y; Yu H; An Y; Wang Y; Tao L; Wang Y; Liu W; Wang T; Xiao R
Brain Pathol; 2019 Jul; 29(4):558-573. PubMed ID: 30582229
[TBL] [Abstract][Full Text] [Related]
11. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
[TBL] [Abstract][Full Text] [Related]
12. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.
Maier M; Peng Y; Jiang L; Seabrook TJ; Carroll MC; Lemere CA
J Neurosci; 2008 Jun; 28(25):6333-41. PubMed ID: 18562603
[TBL] [Abstract][Full Text] [Related]
13. Clathrin-mediated endocytic proteins are upregulated in the cortex of the Tg2576 mouse model of Alzheimer's disease-like amyloid pathology.
Thomas RS; Lelos MJ; Good MA; Kidd EJ
Biochem Biophys Res Commun; 2011 Dec; 415(4):656-61. PubMed ID: 22079091
[TBL] [Abstract][Full Text] [Related]
14. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
15. Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions.
van Groen T; Liu L; Ikonen S; Kadish I
Neuroscience; 2003; 119(4):1185-97. PubMed ID: 12831872
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition.
Chakrabarty P; Tianbai L; Herring A; Ceballos-Diaz C; Das P; Golde TE
Mol Neurodegener; 2012 Jul; 7():36. PubMed ID: 22838967
[TBL] [Abstract][Full Text] [Related]
17. Fimbria-fornix lesion does not affect APP levels and amyloid deposition in the hippocampus of APP+PS1 double transgenic mice.
Liu L; Ikonen S; Tapiola T; Tanila H; van Groen T
Exp Neurol; 2002 Oct; 177(2):565-74. PubMed ID: 12429202
[TBL] [Abstract][Full Text] [Related]
18. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice.
Dewachter I; Reversé D; Caluwaerts N; Ris L; Kuipéri C; Van den Haute C; Spittaels K; Umans L; Serneels L; Thiry E; Moechars D; Mercken M; Godaux E; Van Leuven F
J Neurosci; 2002 May; 22(9):3445-53. PubMed ID: 11978821
[TBL] [Abstract][Full Text] [Related]
19. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
20. Proteins Involved in Endocytosis Are Upregulated by Ageing in the Normal Human Brain: Implications for the Development of Alzheimer's Disease.
Alsaqati M; Thomas RS; Kidd EJ
J Gerontol A Biol Sci Med Sci; 2018 Mar; 73(3):289-298. PubMed ID: 28655199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
